As part of its ongoing quest to hold McKesson accountable for its role in the opioid crisis, the International Brotherhood of Teamsters is urging shareholders in the big wholesaler not to re-elect the audit committee chairperson.

In a regulatory filing, the Teamsters argued that the committee, which is headed by Marie Knowles, has failed to conduct proper oversight of anti-diversion practices that led to a $150 million fine last year for failing to report suspicious orders of controlled substances. A decade ago, the wholesaler paid a $13 million civil penalty for similar violations assessed by the Drug Enforcement Administration.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy